Three multicenter, randomized, double‐blind, placebo‐controlled studies evaluating the efficacy and safety of ustekinumab in axial spondyloarthritis
…, MLG Vivar, J Gratacos, X Juanola… - Arthritis & …, 2019 - Wiley Online Library
Objective To evaluate the efficacy and safety of ustekinumab in 3 randomized, placebo‐controlled
studies in patients with axial spondyloarthritis (SpA). Studies 1 and 2 included patients …
studies in patients with axial spondyloarthritis (SpA). Studies 1 and 2 included patients …
[HTML][HTML] Guidance on noncorticosteroid systemic immunomodulatory therapy in noninfectious uveitis: Fundamentals Of Care for UveitiS (FOCUS) initiative
…, C Hooper, YS Hwang, DK Hwang, X Juanola… - Ophthalmology, 2018 - Elsevier
Topic An international, expert-led consensus initiative to develop systematic, evidence-based
recommendations for the treatment of noninfectious uveitis in the era of biologics. Clinical …
recommendations for the treatment of noninfectious uveitis in the era of biologics. Clinical …
Influence of previous corticosteroid therapy on temporal artery biopsy yield in giant cell arteritis
…, C Gómez-Vaquero, X Juanola… - Seminars in arthritis and …, 2007 - Elsevier
OBJECTIVE: To determine the impact of prior corticosteroid treatment on temporal artery
biopsy (TAB) yield to establish the diagnosis of giant cell arteritis (GCA). METHODS: …
biopsy (TAB) yield to establish the diagnosis of giant cell arteritis (GCA). METHODS: …
Etanercept 50 mg once weekly is as effective as 25 mg twice weekly in patients with ankylosing spondylitis
…, I Van der Horst-Bruinsma, X Juanola… - Annals of the …, 2006 - ard.bmj.com
Objective: To compare the efficacy, pharmacokinetics and safety of etanercept 50 mg once
weekly with 25 mg twice weekly and placebo in patients with ankylosing spondylitis. Methods: …
weekly with 25 mg twice weekly and placebo in patients with ankylosing spondylitis. Methods: …
First signs and symptoms of spondyloarthritis—data from an inception cohort with a disease course of two years or less (REGISPONSER-Early)
…, R Almodovar, J Gratacos, J Mulero, X Juanola… - …, 2009 - academic.oup.com
Objective. To determine the first signs and symptoms, and the clinical, biological and
radiological characteristics of patients with early SpA. Methods. A total of 150 SpA patients were …
radiological characteristics of patients with early SpA. Methods. A total of 150 SpA patients were …
[HTML][HTML] The value of repeat biopsy in lupus nephritis flares
…, X Fulladosa, O Capdevila, J Torras, X Juanola… - Medicine, 2017 - journals.lww.com
Whether a repeat renal biopsy is helpful during lupus nephritis (LN) flares remains debatable.
In order to analyze the clinical utility of repeat renal biopsy in this complex situation, we …
In order to analyze the clinical utility of repeat renal biopsy in this complex situation, we …
Description and prevalence of spondyloarthritis in patients with anterior uveitis: the SENTINEL Interdisciplinary Collaborative Project
X Juanola, EL Santamaría, M Cordero-Coma… - Ophthalmology, 2016 - Elsevier
… Author links open overlay panel Xavier Juanola MD, PhD 1 , Estíbaliz Loza Santamaría
MD 2 , Miguel Cordero-Coma MD, PhD 3 4 , SENTINEL … Data collection: Juanola, Cordero-Coma …
MD 2 , Miguel Cordero-Coma MD, PhD 3 4 , SENTINEL … Data collection: Juanola, Cordero-Coma …
[PDF][PDF] Outcome of an education and home-based exercise programme for patients with ankylosing spondylitis: a nationwide randomized study
C Rodriguez-Lozano, X Juanola… - Clin Exp …, 2013 - clinexprheumatol.org
… Ginés Sánchez Nievas, Isabel Labiano Bastero, Rebeca Belmonte Moreno, Manuela Sianes
Fernández, Enrique Judez Navarro, María Ángeles García Morales, Gloria García-Consuegra …
Fernández, Enrique Judez Navarro, María Ángeles García Morales, Gloria García-Consuegra …
[HTML][HTML] Non-inferiority of dose reduction versus standard dosing of TNF-inhibitors in axial spondyloarthritis
J Gratacós, C Pontes, X Juanola, J Sanz… - Arthritis research & …, 2019 - Springer
Objective The objective was to determine if dose reduction is non-inferior to full-dose TNFi
to maintain low disease activity (LDA) in patients already in remission with TNFi, in axial …
to maintain low disease activity (LDA) in patients already in remission with TNFi, in axial …
Prevalence of vertebral fractures by semiautomated morphometry in patients with ankylosing spondylitis
N Montala, X Juanola, E Collantes… - The Journal of …, 2011 - jrheum.org
Objective. Ankylosing spondylitis (AS) is a chronic inflammatory disease mainly affecting the
axial skeleton and characterized by ossification of the spinal disc, joints, and ligaments …
axial skeleton and characterized by ossification of the spinal disc, joints, and ligaments …